VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $335,266 | -2.9% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $345,441 | -8.1% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $375,966 | -28.4% | 50,875 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $525,000 | -57.0% | 53,110 | -50.8% | 0.00% | -42.9% |
| Q1 2022 | $1,221,000 | -27.9% | 107,985 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $1,694,000 | -8.5% | 107,985 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $1,851,000 | -20.3% | 107,985 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $2,323,000 | +43.2% | 107,985 | 0.0% | 0.02% | +35.7% |
| Q1 2021 | $1,622,000 | +101.5% | 107,985 | +76.2% | 0.01% | +100.0% |
| Q4 2020 | $805,000 | +160.5% | 61,300 | +91.6% | 0.01% | +133.3% |
| Q3 2020 | $309,000 | -53.3% | 32,000 | -20.6% | 0.00% | -50.0% |
| Q4 2019 | $661,000 | -29.8% | 40,300 | -43.2% | 0.01% | -33.3% |
| Q3 2019 | $942,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |